25 Nov 2020 07:00
25 November 2020
DeepVerge PLC
("DeepVerge" or "the Company")
Investor presentation and corporate update following Modern Water plc acquisition
DeepVerge (LSE:DVRG.L), the scientific research and AI-as-a-Service company, is pleased to announce that Gerry Brandon, Chief Executive Officer, will be presenting at an investor webinar being hosted jointly by Turner Pope Investments (TPI) Ltd and Vox Markets.
The event will be held on Tuesday 1st December 2020 at 2pm. Please register your interest at https://voxmarkets.brand.live/c/deepverge-webinar
Gerard Brandon, CEO of DeepVerge, Commented:
"Deepverge is expanding, with organic revenue growth alone, despite COVID, guided at £4m for 2020, including an increase in revenues by 300% in H2 2020, up from £1m in H1 2020. Following the recent acquisition of Modern Water plc, we will now have sales offices and laboratories for Labskin and Rinocloud AI services in the US, Ireland, UK, China and Japan. This global expansion provides access to a growing list of household name clients, that includes Unilever, L'Oréal, Estee Lauder, Walgreens Boots Alliance, Amway and L'Occitane, cross-selling products and services from each division and serving the environment, cosmetics and pharma sectors worldwide.
"The presentation will provide an update on sales, marketing, supply chain management of products and services under development in a post-COVID world with insight into what is expected to come in 2021 and 2022."
For further information please contact:
DeepVerge plc | Gerard Brandon, CEO
| +44 (0) 7340 055 648 |
SPARK Advisory Partners Limited (Nominated Adviser)
| Neil Baldwin/Andrew Emmott | +44 (0) 113 370 8974 |
Turner Pope Investments (TPI) Limited (Broker) | Andy Thacker/Zoe Alexander | +44 (0) 20 3657 0050 |
About DeepVerge plc (www.deepverge.com)
DeepVerge is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 20 global cosmetic company clients to remotely detecting water contamination in real-time.
In November 2020, DeepVerge acquired Modern Water who developed and commercialised a cutting-edge technology, focused on monitoring of contaminated water and decontamination of wastewater, making recycling of water more efficient. Six countries across the world have legislated that Modern Water monitoring test systems are written into their environmental protection legislation. The Company is in final trials for its real-time contamination product, Microtox PD, for the identification of COVID-19 hotspots and other pathogens.